NCT00678574View on ClinicalTrials.gov

The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Premenstrual Dysphoric DisorderPremenstrual Syndrome
Interventions
DRUG

fluoxetine

Fluoxetine 20 mg daily by mouth for 2-3 months.

Trial Locations (1)

06511

Yale University, New Haven

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Pennsylvania

OTHER

NCT00678574 - The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder | Biotech Hunter | Biotech Hunter